510(k) K162042
K162042 is an FDA 510(k) premarket notification submitted by Optiscan Biomedical Corp. for the device "OptiScanner 5000 Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on October 16, 2017. The device falls under product code LZF (Pump, Infusion, Analytical Sampling), a Class II device regulated under 21 CFR 880.5725.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- October 16, 2017
- Date Received
- July 25, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Pump, Infusion, Analytical Sampling
- Device Class
- Class II
- Regulation Number
- 880.5725
- Review Panel
- CH
- Submission Type